SPOTLIGHT -
Will Clinical Psychiatry Go the Way of the Rubin Museum in New York?
Does seeing art live vs online impact the brain differently?
The Week in Review: January 29-February 2
From the impact of BMI on clinical features of bipolar disorder to FDA approval of the first integrated TMS system for MDD and OCD, here are highlights from the week in Psychiatric Times.
Depression Research Roundup: February 2, 2024
What is new in research on depression?
The Case for a Social Classification of Social Psychopathologies
We need improved recognition of the social determinants of mental health.
The Impact of BMI on Clinical Features of Bipolar Disorder
“Weight” a minute! Researchers investigated the impact of body mass index on the clinical features of bipolar disorder in the STEP-BD study.
Presenting Our February Theme: Eating Disorders
Write to us now to be part of our series focused on eating disorders this month.
Frank Clark, MD: The First Black President of The Greenville County Medical Society
Frank Clark, MD, the Psychiatric Times Diversity & Inclusion Section Editor, was recently appointed president of The Greenville County Medical Society, the first Black doctor to serve in this role.
Writing Spitballs into the Future
Do you know the all the many meanings of the word spitball? How does it apply to psychiatry?
February Is Black History Month
We're looking for articles with an emphasis on clinical care for marginalized populations...
Bella, Horrida Bella
“In the realm of psychiatry, the therapeutic value of poetry lies in its ability to transcend the limitations of prose, offering a space for the unsayable and the ineffable.”
4 Questions About Burnout
An expert discusses the common causes of burnout, as well as what both organizations and clinicians can do to support clinician well-being.
Recap: Clinician Wellness 2024
Here’s a look back at selections from our January content series on clinician wellness.
Poll: Are You Surprised by the Discontinuation of Aducanumab?
Biogen announced its decision to discontinue all development and sales of aducanumab (Aduhelm) for Alzheimer disease. Is this surprising?
Get Cozy and Keep Sleeping
Here’s how we can help improve quality of sleep in both our patients and ourselves.
Biogen Discontinues Aducanumab for Alzheimer Disease
Biogen has officially announced its decision to discontinue all development and sales of aducanumab (Aduhelm) for Alzheimer disease.
Psychiatry in the News: January 2024
Here are some updates from the world of psychiatry throughout the month of January.
Pushing the Panic Button Hid the Real Risks
When exploring urgent treatment options for your patients, be sure to look at the bigger picture before you push the panic button.
First Integrated TMS System for Major Depressive Disorder, Obsessive-Compulsive Disorder
The FDA granted clearance for a transcranial magnetic stimulation technology indicated for major depressive disorder and obsessive-compulsive disorder.
January: “National Poverty in America Awareness Month”
Did you know January is Poverty Awareness Month?
Once Daily Versus Divided Dosing Regimens of Clozapine
To divide or not to divide? Researchers compared clinical features, side effects, and blood levels between once daily versus divided clozapine dosing regimens.
A Unifying Cultural Model at Ball State
The unity students have shown at Ball State is a model worth replicating.
From the Pages of Psychiatric Times: January 2024
The experts weighed in on a wide variety of psychiatric issues for the January 2024 issue of Psychiatric Times.
The Week in Review: January 22-26
From noninvasive brain stimulation for substance use disorders to updates from APSARD 2024, here are highlights from the week in Psychiatric Times.
Emotional Intelligence for Mitigating Burnout and Enhancing Well-Being
A "global human energy crisis" is coming. How can emotional intelligence help us navigate it?
Clinician Wellness Research Roundup: January 26, 2024
What is new in research on clinician wellness?
Are You Still Feeling Burned Out?
The latest report on physician burnout is here...
Drug Candidate for Schizophrenia, Alzheimer Disease Approved to Initiate Phase 2 Trial in Q2 2024
The candidate also aims to address neurodevelopmental and neurodegenerative disorders such as Parkinson disease and Rett syndrome.
Late Breaking News From APSARD 2024 Conference
Check out these APSARD 2024 updates from Greg Mattingly, MD, president of the American Professional Society for ADHD and Related Disorders.
What Can and Should Psychiatrists Say About the Presidential Races in the United States and Elsewhere?
Election year has rolled around again… what role do psychiatrists and mental health clinicians play in these tense times?
Addressing Suicide and Other Mental Health Crises With 988
US suicide rates reached an all-time high in 2022. Here’s how effective implementation of 988 can help address the problem.